ReShape Lifesciences Reviews
Honest patient reviews and ratings for ReShape Lifesciences peptide therapy services.
Telehealth Ally is editorially independent. Revenue never influences our rankings.
Our Verdict
ReShape Lifesciences is a telehealth provider. They offer hybrid consultations.
Quick Facts
Consultation
Hybrid
Lab Testing
Not included
Peptides Offered
2
Shipping
3-5 business days
All Patient Reviews (0)
No patient reviews on Telehealth Ally yet for ReShape Lifesciences. Be the first to share your experience.
Frequently Asked Questions
Is ReShape Lifesciences legit?
ReShape Lifesciences has 0 patient reviews . They offer hybrid consultations. Founded in 2012, they are based in Eden Prairie, MN.
How much does ReShape Lifesciences cost?
Contact ReShape Lifesciences for current pricing information.
What peptides does ReShape Lifesciences offer?
ReShape Lifesciences offers 2 peptides: Semaglutide, Tirzepatide.
Have you used ReShape Lifesciences?
Share your honest experience to help others make informed decisions. Verified reviews are prioritized — we'll ask you to confirm via email.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →